HEADER PEPTIDE BINDING PROTEIN 20-NOV-01 1KFF TITLE AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II TITLE 2 PEPTIDE: APO-SAM1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: STREPTAVIDIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES AVIDINII; SOURCE 3 ORGANISM_TAXID: 1895; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PSA1 KEYWDS BIOTIN, PROTEIN ENGINEERING, STREP-TAG, STREPTAVIDIN, PEPTIDE BINDING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR I.P.KORNDOERFER,A.SKERRA REVDAT 6 16-AUG-23 1KFF 1 REMARK REVDAT 5 27-OCT-21 1KFF 1 SEQADV REVDAT 4 24-FEB-09 1KFF 1 VERSN REVDAT 3 01-APR-03 1KFF 1 JRNL REVDAT 2 01-MAY-02 1KFF 1 HEADER REVDAT 1 03-APR-02 1KFF 0 JRNL AUTH I.P.KORNDORFER,A.SKERRA JRNL TITL IMPROVED AFFINITY OF ENGINEERED STREPTAVIDIN FOR THE JRNL TITL 2 STREP-TAG II PEPTIDE IS DUE TO A FIXED OPEN CONFORMATION OF JRNL TITL 3 THE LID-LIKE LOOP AT THE BINDING SITE. JRNL REF PROTEIN SCI. V. 11 883 2002 JRNL REFN ISSN 0961-8368 JRNL PMID 11910031 JRNL DOI 10.1110/PS.4150102 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.3 REMARK 3 NUMBER OF REFLECTIONS : 32808 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1650 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3588 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 212 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.17000 REMARK 3 B22 (A**2) : 1.37000 REMARK 3 B33 (A**2) : -0.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.05000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.167 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.161 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.152 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.100 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.016 ; 0.021 REMARK 3 ANGLE DISTANCE (A) : 2.868 ; 1.884 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KFF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-NOV-01. REMARK 100 THE DEPOSITION ID IS D_1000014897. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JAN-01 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33063 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 41.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.2 REMARK 200 DATA REDUNDANCY : 1.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05100 REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31100 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1SWU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM NA2HPO4, 1.2-M (NH4)2SO4, PH REMARK 280 7.3, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.45800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS ONE OF THE TETRAMERS IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 13 REMARK 465 GLU A 14 REMARK 465 ALA A 15 REMARK 465 SER A 136 REMARK 465 ALA A 137 REMARK 465 ALA A 138 REMARK 465 SER A 139 REMARK 465 MET B 13 REMARK 465 GLU B 14 REMARK 465 PRO B 135 REMARK 465 SER B 136 REMARK 465 ALA B 137 REMARK 465 ALA B 138 REMARK 465 SER B 139 REMARK 465 MET C 13 REMARK 465 GLU C 14 REMARK 465 ALA C 15 REMARK 465 PRO C 135 REMARK 465 SER C 136 REMARK 465 ALA C 137 REMARK 465 ALA C 138 REMARK 465 SER C 139 REMARK 465 MET D 13 REMARK 465 GLU D 14 REMARK 465 ALA D 15 REMARK 465 PRO D 135 REMARK 465 SER D 136 REMARK 465 ALA D 137 REMARK 465 ALA D 138 REMARK 465 SER D 139 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLY A 68 O HOH A 181 1.65 REMARK 500 OD2 ASP C 128 O HOH C 189 1.66 REMARK 500 O ASN B 81 O HOH B 181 2.04 REMARK 500 N GLU C 101 O HOH C 185 2.11 REMARK 500 NE2 GLN D 24 OD1 ASP D 128 2.14 REMARK 500 OH TYR A 22 O HOH A 165 2.15 REMARK 500 OE1 GLN C 24 OD1 ASP C 128 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 56 CB - CG - CD1 ANGL. DEV. = -11.6 DEGREES REMARK 500 ASP A 61 CB - CG - OD1 ANGL. DEV. = 7.8 DEGREES REMARK 500 ASP A 67 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 TRP A 92 CA - CB - CG ANGL. DEV. = 11.4 DEGREES REMARK 500 GLU B 51 OE1 - CD - OE2 ANGL. DEV. = -9.4 DEGREES REMARK 500 LEU B 56 CB - CG - CD2 ANGL. DEV. = -12.3 DEGREES REMARK 500 ARG B 84 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG B 84 NE - CZ - NH2 ANGL. DEV. = -6.3 DEGREES REMARK 500 GLN B 107 CA - CB - CG ANGL. DEV. = -16.2 DEGREES REMARK 500 PHE C 29 CB - CA - C ANGL. DEV. = 15.4 DEGREES REMARK 500 PHE C 29 N - CA - CB ANGL. DEV. = -12.2 DEGREES REMARK 500 ARG C 53 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG C 59 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 LEU D 39 CB - CG - CD2 ANGL. DEV. = 11.6 DEGREES REMARK 500 ASP D 128 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 25 8.97 -67.52 REMARK 500 ASP B 67 9.61 -69.53 REMARK 500 GLU B 101 61.84 -103.93 REMARK 500 ALA C 46 -35.02 -38.07 REMARK 500 TRP C 79 54.45 -90.72 REMARK 500 GLU C 101 48.97 -88.48 REMARK 500 ASN D 81 -153.27 -139.23 REMARK 500 GLU D 101 45.46 75.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RSU RELATED DB: PDB REMARK 900 COMPLEX BETWEEN WILD-TYPE STREPTAVIDIN AND THE STREP-TAG II PEPTIDE REMARK 900 RELATED ID: 1KL3 RELATED DB: PDB REMARK 900 AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG REMARK 900 II PEPTIDE : SAM1-STREPII REMARK 900 RELATED ID: 1KL4 RELATED DB: PDB REMARK 900 AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG REMARK 900 II PEPTIDE : APO-SAM2 REMARK 900 RELATED ID: 1KL5 RELATED DB: PDB REMARK 900 AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG REMARK 900 II PEPTIDE : : SAM2-STREPII DBREF 1KFF A 14 139 UNP P22629 SAV_STRAV 38 163 DBREF 1KFF B 14 139 UNP P22629 SAV_STRAV 38 163 DBREF 1KFF C 14 139 UNP P22629 SAV_STRAV 38 163 DBREF 1KFF D 14 139 UNP P22629 SAV_STRAV 38 163 SEQADV 1KFF MET A 13 UNP P22629 INITIATING METHIONINE SEQADV 1KFF VAL A 44 UNP P22629 GLU 68 ENGINEERED MUTATION SEQADV 1KFF THR A 45 UNP P22629 SER 69 ENGINEERED MUTATION SEQADV 1KFF ARG A 47 UNP P22629 VAL 71 ENGINEERED MUTATION SEQADV 1KFF MET B 13 UNP P22629 INITIATING METHIONINE SEQADV 1KFF VAL B 44 UNP P22629 GLU 68 ENGINEERED MUTATION SEQADV 1KFF THR B 45 UNP P22629 SER 69 ENGINEERED MUTATION SEQADV 1KFF ARG B 47 UNP P22629 VAL 71 ENGINEERED MUTATION SEQADV 1KFF MET C 13 UNP P22629 INITIATING METHIONINE SEQADV 1KFF VAL C 44 UNP P22629 GLU 68 ENGINEERED MUTATION SEQADV 1KFF THR C 45 UNP P22629 SER 69 ENGINEERED MUTATION SEQADV 1KFF ARG C 47 UNP P22629 VAL 71 ENGINEERED MUTATION SEQADV 1KFF MET D 13 UNP P22629 INITIATING METHIONINE SEQADV 1KFF VAL D 44 UNP P22629 GLU 68 ENGINEERED MUTATION SEQADV 1KFF THR D 45 UNP P22629 SER 69 ENGINEERED MUTATION SEQADV 1KFF ARG D 47 UNP P22629 VAL 71 ENGINEERED MUTATION SEQRES 1 A 127 MET GLU ALA GLY ILE THR GLY THR TRP TYR ASN GLN LEU SEQRES 2 A 127 GLY SER THR PHE ILE VAL THR ALA GLY ALA ASP GLY ALA SEQRES 3 A 127 LEU THR GLY THR TYR VAL THR ALA ARG GLY ASN ALA GLU SEQRES 4 A 127 SER ARG TYR VAL LEU THR GLY ARG TYR ASP SER ALA PRO SEQRES 5 A 127 ALA THR ASP GLY SER GLY THR ALA LEU GLY TRP THR VAL SEQRES 6 A 127 ALA TRP LYS ASN ASN TYR ARG ASN ALA HIS SER ALA THR SEQRES 7 A 127 THR TRP SER GLY GLN TYR VAL GLY GLY ALA GLU ALA ARG SEQRES 8 A 127 ILE ASN THR GLN TRP LEU LEU THR SER GLY THR THR GLU SEQRES 9 A 127 ALA ASN ALA TRP LYS SER THR LEU VAL GLY HIS ASP THR SEQRES 10 A 127 PHE THR LYS VAL LYS PRO SER ALA ALA SER SEQRES 1 B 127 MET GLU ALA GLY ILE THR GLY THR TRP TYR ASN GLN LEU SEQRES 2 B 127 GLY SER THR PHE ILE VAL THR ALA GLY ALA ASP GLY ALA SEQRES 3 B 127 LEU THR GLY THR TYR VAL THR ALA ARG GLY ASN ALA GLU SEQRES 4 B 127 SER ARG TYR VAL LEU THR GLY ARG TYR ASP SER ALA PRO SEQRES 5 B 127 ALA THR ASP GLY SER GLY THR ALA LEU GLY TRP THR VAL SEQRES 6 B 127 ALA TRP LYS ASN ASN TYR ARG ASN ALA HIS SER ALA THR SEQRES 7 B 127 THR TRP SER GLY GLN TYR VAL GLY GLY ALA GLU ALA ARG SEQRES 8 B 127 ILE ASN THR GLN TRP LEU LEU THR SER GLY THR THR GLU SEQRES 9 B 127 ALA ASN ALA TRP LYS SER THR LEU VAL GLY HIS ASP THR SEQRES 10 B 127 PHE THR LYS VAL LYS PRO SER ALA ALA SER SEQRES 1 C 127 MET GLU ALA GLY ILE THR GLY THR TRP TYR ASN GLN LEU SEQRES 2 C 127 GLY SER THR PHE ILE VAL THR ALA GLY ALA ASP GLY ALA SEQRES 3 C 127 LEU THR GLY THR TYR VAL THR ALA ARG GLY ASN ALA GLU SEQRES 4 C 127 SER ARG TYR VAL LEU THR GLY ARG TYR ASP SER ALA PRO SEQRES 5 C 127 ALA THR ASP GLY SER GLY THR ALA LEU GLY TRP THR VAL SEQRES 6 C 127 ALA TRP LYS ASN ASN TYR ARG ASN ALA HIS SER ALA THR SEQRES 7 C 127 THR TRP SER GLY GLN TYR VAL GLY GLY ALA GLU ALA ARG SEQRES 8 C 127 ILE ASN THR GLN TRP LEU LEU THR SER GLY THR THR GLU SEQRES 9 C 127 ALA ASN ALA TRP LYS SER THR LEU VAL GLY HIS ASP THR SEQRES 10 C 127 PHE THR LYS VAL LYS PRO SER ALA ALA SER SEQRES 1 D 127 MET GLU ALA GLY ILE THR GLY THR TRP TYR ASN GLN LEU SEQRES 2 D 127 GLY SER THR PHE ILE VAL THR ALA GLY ALA ASP GLY ALA SEQRES 3 D 127 LEU THR GLY THR TYR VAL THR ALA ARG GLY ASN ALA GLU SEQRES 4 D 127 SER ARG TYR VAL LEU THR GLY ARG TYR ASP SER ALA PRO SEQRES 5 D 127 ALA THR ASP GLY SER GLY THR ALA LEU GLY TRP THR VAL SEQRES 6 D 127 ALA TRP LYS ASN ASN TYR ARG ASN ALA HIS SER ALA THR SEQRES 7 D 127 THR TRP SER GLY GLN TYR VAL GLY GLY ALA GLU ALA ARG SEQRES 8 D 127 ILE ASN THR GLN TRP LEU LEU THR SER GLY THR THR GLU SEQRES 9 D 127 ALA ASN ALA TRP LYS SER THR LEU VAL GLY HIS ASP THR SEQRES 10 D 127 PHE THR LYS VAL LYS PRO SER ALA ALA SER FORMUL 5 HOH *212(H2 O) HELIX 1 1 ASN A 49 GLU A 51 5 3 HELIX 2 2 THR A 115 LYS A 121 5 7 HELIX 3 3 ASN B 49 GLU B 51 5 3 HELIX 4 4 THR B 115 LYS B 121 5 7 HELIX 5 5 ASN C 49 GLU C 51 5 3 HELIX 6 6 THR C 115 LYS C 121 5 7 HELIX 7 7 ASN D 49 GLU D 51 5 3 HELIX 8 8 THR D 115 LYS D 121 5 7 SHEET 1 A 9 GLY A 19 ASN A 23 0 SHEET 2 A 9 THR A 28 ALA A 33 -1 O PHE A 29 N TRP A 21 SHEET 3 A 9 ALA A 38 VAL A 44 -1 O THR A 42 N ILE A 30 SHEET 4 A 9 ARG A 53 TYR A 60 -1 O TYR A 54 N TYR A 43 SHEET 5 A 9 THR A 71 LYS A 80 -1 O THR A 76 N THR A 57 SHEET 6 A 9 ASN A 85 VAL A 97 -1 O GLY A 94 N LEU A 73 SHEET 7 A 9 ARG A 103 SER A 112 -1 O THR A 111 N ALA A 89 SHEET 8 A 9 THR A 123 THR A 131 -1 O PHE A 130 N ILE A 104 SHEET 9 A 9 GLY A 19 ASN A 23 -1 N TYR A 22 O THR A 131 SHEET 1 B 9 GLY B 19 TYR B 22 0 SHEET 2 B 9 THR B 28 ALA B 33 -1 O VAL B 31 N GLY B 19 SHEET 3 B 9 ALA B 38 VAL B 44 -1 O VAL B 44 N THR B 28 SHEET 4 B 9 ARG B 53 TYR B 60 -1 O TYR B 54 N TYR B 43 SHEET 5 B 9 THR B 71 LYS B 80 -1 O THR B 76 N THR B 57 SHEET 6 B 9 ASN B 85 VAL B 97 -1 O THR B 90 N VAL B 77 SHEET 7 B 9 ARG B 103 SER B 112 -1 O GLN B 107 N SER B 93 SHEET 8 B 9 THR B 123 THR B 131 -1 O LEU B 124 N LEU B 110 SHEET 9 B 9 GLY B 19 TYR B 22 -1 N TYR B 22 O THR B 131 SHEET 1 C 9 GLY C 19 ASN C 23 0 SHEET 2 C 9 THR C 28 ALA C 33 -1 O PHE C 29 N TRP C 21 SHEET 3 C 9 ALA C 38 VAL C 44 -1 O VAL C 44 N THR C 28 SHEET 4 C 9 ARG C 53 TYR C 60 -1 O TYR C 54 N TYR C 43 SHEET 5 C 9 THR C 71 LYS C 80 -1 O THR C 76 N THR C 57 SHEET 6 C 9 ASN C 85 VAL C 97 -1 O TYR C 96 N THR C 71 SHEET 7 C 9 ARG C 103 SER C 112 -1 O ARG C 103 N VAL C 97 SHEET 8 C 9 THR C 123 THR C 131 -1 O PHE C 130 N ILE C 104 SHEET 9 C 9 GLY C 19 ASN C 23 -1 N TYR C 22 O THR C 131 SHEET 1 D 9 GLY D 19 TYR D 22 0 SHEET 2 D 9 THR D 28 ALA D 33 -1 O PHE D 29 N TRP D 21 SHEET 3 D 9 ALA D 38 VAL D 44 -1 O VAL D 44 N THR D 28 SHEET 4 D 9 ARG D 53 TYR D 60 -1 O TYR D 54 N TYR D 43 SHEET 5 D 9 THR D 71 LYS D 80 -1 O THR D 76 N THR D 57 SHEET 6 D 9 ASN D 85 VAL D 97 -1 O TRP D 92 N TRP D 75 SHEET 7 D 9 ARG D 103 SER D 112 -1 O GLN D 107 N SER D 93 SHEET 8 D 9 THR D 123 THR D 131 -1 O ASP D 128 N THR D 106 SHEET 9 D 9 GLY D 19 TYR D 22 -1 N TYR D 22 O THR D 131 CISPEP 1 ALA B 15 GLY B 16 0 5.91 CRYST1 58.419 86.916 47.196 90.00 98.90 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017118 0.000000 0.002681 0.00000 SCALE2 0.000000 0.011505 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021446 0.00000